MRK

Merck & Co.

Health Care

Pharmaceuticals

Kenilworth, New Jersey

Last filing: Feb 24, 2026 (FY2025)

Account	2025	2024	2023	2022	2021
BS_Assets_Cash	$0	$13.2B	$6.8B	$12.7B	$8.1B
BS_Assets_ShortTermInvest	$0	$920.0M	$764.0M	$498.0M	$1.6B
BS_Assets_AcctsReceivable	$0	$10.3B	$10.3B	$9.4B	$9.2B
BS_Assets_PPE	$0	$23.8B	$23.1B	$21.4B	$19.3B
BS_Assets_Goodwill	$17.0M	$21.7B	$21.2B	$21.2B	$21.3B
BS_Assets_IntangibleAssets	$0	$16.4B	$18.0B	$20.3B	$22.9B
BS_Assets_OtherNoncurrent	$0	$16.0B	$12.0B	$2.9B	$2.2B
BS_Liab_AccruedLiab	$0	$6.0B	$4.6B	$3.9B	$3.0B
BS_Liab_OtherNoncurrent	$0	$6.5B	$8.8B	$8.3B	$9.4B
BS_Equity_PreferredStock	$0	$0	$0	$0	$0
BS_Equity_CommonStock	$0	$1.8B	$1.8B	$1.8B	$1.8B
BS_Equity_TreasuryStock	$5.1B	$1.3B	$1.3B	$56.5B	$840.0M
BS_Equity_AOCI	$0	$-4.9B	$-5.2B	$-4.8B	$-4.4B

Account	2025	2024	2023	2022	2021
IS_Revenue_Total	$65.0B	$64.2B	$60.1B	$59.3B	$48.7B
IS_Expense_COGS	$16.4B	$15.2B	$16.1B	$17.4B	$13.6B
IS_Expense_RnD	$15.8B	$17.9B	$30.5B	$13.5B	$12.2B
IS_Expense_SGA	$10.7B	$10.8B	$10.5B	$10.0B	$9.6B
IS_Expense_DA	$2.8B	$2.4B	$2.0B	$2.1B	$1.6B
IS_Expense_SBC	$820.0M	$761.0M	$645.0M	$541.0M	$479.0M
IS_Expense_Restructuring	$889.0M	$309.0M	$599.0M	$337.0M	$661.0M
IS_OperatingIncome	$18.3B	$17.1B	$365.0M	$14.5B	$12.3B
IS_InterestIncome	$343.0M	$415.0M	$365.0M	$157.0M	$36.0M
IS_InterestExpense	$1.4B	$1.3B	$1.1B	$962.0M	$806.0M
IS_OtherNonopIncExp	$-151.0M	$24.0M	$-466.0M	$-1.5B	$1.3B
IS_PreTaxIncome	$21.1B	$19.9B	$1.9B	$16.4B	$13.9B
IS_TaxExpense	$2.8B	$2.8B	$1.5B	$1.9B	$1.5B
IS_NetIncome	$18.3B	$17.1B	$365.0M	$14.5B	$13.0B
IS_ComprehensiveIncome	$18.9B	$17.3B	$-28.0M	$14.2B	$14.8B
IS_EPS_Basic	$7	$7	$0	$6	$5
IS_EPS_Diluted	$7	$7	$0	$6	$5
IS_Shares_Basic	$2.5B	$2.5B	$2.5B	$2.5B	$2.5B
IS_Shares_Diluted	$2.5B	$2.5B	$2.5B	$2.5B	$2.5B

Account	2025	2024	2023	2022	2021
CF_Ops_NetIncome	$18.3B	$17.1B	$365.0M	$14.5B	$13.0B
CF_Ops_DA	$3.0B	$2.1B	$1.8B	$1.8B	$1.6B
CF_Ops_SBC	$820.0M	$761.0M	$645.0M	$541.0M	$479.0M
CF_Ops_DeferredTax	$-1.7B	$-1.2B	$-1.9B	$-1.6B	$187.0M
CF_Ops_WorkingCapital	$429.0M	$-1.2B	$3.7B	$755.0M	$3.0B
CF_Ops_Other	$195.0M	$-49.0M	$456.0M	$-545.0M	$484.0M
CF_Ops_NetCash	$16.5B	$21.5B	$13.0B	$19.1B	—
CF_Inv_Capex	$4.1B	$3.4B	$3.9B	$4.4B	$4.4B
CF_Inv_Acquisitions	$10.0B	$0	$0	$0	$179.0M
CF_Inv_PurchaseInvestments	$1.2B	$519.0M	$955.0M	$1.2B	$1.0M
CF_Inv_Other	$58.0M	$127.0M	$36.0M	$89.0M	$91.0M
CF_Inv_NetCash	$-13.7B	$-7.7B	$-14.1B	$-5.0B	—
CF_Fin_DebtRepayment	$2.5B	$1.3B	$1.8B	$2.3B	$2.3B
CF_Fin_ShareRepurchases	$5.1B	$1.3B	$1.3B	$0	$840.0M
CF_Fin_Dividends	$8.2B	$7.8B	$7.4B	$7.0B	$6.6B
CF_Fin_StockIssuance	$92.0M	$177.0M	$125.0M	$384.0M	$202.0M
CF_Fin_Other	$-131.0M	$-372.0M	$-328.0M	$-240.0M	$-286.0M
CF_Fin_NetCash	$-1.9B	$-7.0B	$-4.8B	$-9.1B	—
CF_FX_Effect	$563.0M	$-293.0M	$23.0M	$-410.0M	$-133.0M
CF_Net_Change	$1.4B	$6.4B	$-5.9B	$4.6B	$14.0M

Stock price history for MRK hasn't been loaded yet.